Investor Stock List
Ranked #7,137 of 8,699 institutional investors

BML Capital Management, LLC

Zionsville, IN

$147M
US stock portfolio at live prices · today −$1.5M (−1.04%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$186M
Change from Q2 2026
+$11.3M (+6.45%)
Positions
17 · 3 new, 0 sold out
Filed
Nov 6, 2026

Not counted in the ranking: put options on $1.2M. $4.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ACRS 26.0%AVIR 18.0%KHC 8.03%ENGN 7.96%PMVP 6.51%
StockSharesValue, live% of portfoliovs Q2 2026
ACRS Aclaris Therapeutics, Inc.10,955,000$38.3M26.0%Reduced −9%
AVIR Atea Pharmaceuticals, Inc.6,753,658$26.5M18.0%Reduced −3%
KHC The Kraft Heinz Company475,000$11.8M8.03%Added +2%
ENGN enGene Therapeutics Inc.6,669,908$11.7M7.96%Unchanged
PMVP PMV Pharmaceuticals, Inc.7,330,000$9.6M6.51%Added +38%
TLYS Tilly's, Inc.2,150,000$8.8M5.95%Unchanged
KMX CarMax, Inc.172,500$8.6M5.85%Unchanged
OM Outset Medical, Inc.2,519,701$7.3M4.97%Unchanged
TGT Target Corporation37,500$6.3M4.26%Unchanged
TIL Instil Bio, Inc.645,600$3.6M2.43%Unchanged
ORMP Oramed Pharmaceuticals Inc.884,392$3.3M2.21%Added +2%
SEER Seer, Inc.2,186,587$3.0M2.05%New
JANX Janux Therapeutics, Inc.151,126$1.6M1.05%Reduced −2%
PLRX Pliant Therapeutics, Inc.1,546,137$959K0.65%Unchanged
LENZ LENZ Therapeutics, Inc.283,114$946K0.64%New
IMA ImageneBio, Inc.200,730$799K0.54%Unchanged
KPTIQ Karyopharm Therapeutics Inc.71,839$2K<0.1%New